/* analytics pumch est. 6/16/2014 */
Menu

New Agents and Small Molecules

浏览本CME课程

Release Date: December 20, 2012
Estimated Time of Completion: 15 minutes

Description

The Rheumatology Highlights Report Series is designed for the busy clinician. It provides highlights from key scientific presentations and/or abstracts presented at the national rheumatology meeting. Clinical experts attending this meeting have selected the most significant data to report. Each activity is a 15-minute presentation. Enhancements include downloadable audio, slide sets, and list of related abstracts.

This report reviews the newest data on rheumatoid arthritis (RA) treatment, including tofacitinib and other janus kinase inhibitors.

Learning Objectives

  1. Summarize new data concerning tofacitinib in RA.
  2. Review new data regarding other janus kinase inhibitors in RA.
  3. Highlight other, very new approaches to RA treatment.

Target Audience

This activity is directed to rheumatologists, immunologists, clinical researchers, and allied health professionals, including nurse practitioners and physician assistants.

Activity Director and Faculty

Activity Director

Leonard H. Calabrese, DO
Professor of Medicine
RJ Fasenmyer Chair of Clinical Immunology
Vice Chairman, Department of Rheumatic and Immunologic Diseases
Cleveland Clinic Lerner College of Medicine
Cleveland, Ohio


Faculty

Marc D. Cohen, MD
Emeritus Professor of Medicine
Mayo Clinic
Clinical Professor of Mediciner
University of Colorado Medical Center
Denver, CO

Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician or other health care provider relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this educational activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation or Peking Union Medical College Hospital be liable for any decision made or action taken in reliance upon the information provided through this educational activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty has indicated that he may have a relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:

Leonard Calabrese, DO

Amgen
BMS
Centocor
Genentech/Roche
Pfizer
Sanofi Aventis
Savient

Consulting; Teaching and Speaking
Consulting
Consulting; Teaching and Speaking
Consulting; Teaching and Speaking
Consulting; Teaching and Speaking
Consulting; Data Safety Monitoring Board
Consulting


The following faculty has indicated that she has no relationship which, in the context of her presentation, could be perceived as potential conflict of interest:

Marc Cohen, MD

Begin Activity in English

This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education and Digestive Disease Institute.

How to Obtain Your Certificate of Participation

  1. Participate in the activity.
  2. Login to your account.
  3. Complete the evaluation.
  4. Print your certificate.